A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

HomeTagsVEITHsymposium

VEITHsymposium

Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

"We are excited to receive FDA clearance for the ISR indication, which expands our addressable market for Pantheris to include a high-incidence disease state for which there are few available indicated treatment options," commented Jeff Soinski, Avinger's President and CEO.
Spot_ImgSpot_Img

By using this website you agree to accept Medical Device News Magazine Privacy Policy